Jacqueline-Marie Ferland | Mount Sinai

Biography

Research Topics

Addiction, Brain, Cognitive Neuroscience, Developmental Neurobiology, Neuroscience, Neurotransmitters, Opioid/Cannabinoid Receptors, Prefrontal Cortex, RNA, Systems Neuroscience, Translational Research

Publications

13

Publications

Selected Publications

Dose mediates the protracted effects of adolescent THC exposure on reward and stress reactivity in males relevant to perturbation of the basolateral amygdala transcriptome. Jacqueline Marie N. Ferland, Randall J. Ellis, Gregory Rompala, Joseph A. Landry, James E. Callens, Annie Ly, Micah D. Frier, Teddy O. Uzamere, Yasmin L. Hurd. Molecular Psychiatry

Long-Term Outcomes of Adolescent THC Exposure on Translational Cognitive Measures in Adulthood in an Animal Model and Computational Assessment of Human Data. Jacqueline Marie N. Ferland, Randall J. Ellis, Graeme Betts, Mason M. Silveira, Joao Bronze De Firmino, Catharine A. Winstanley, Yasmin L. Hurd. JAMA Psychiatry

Cannabis and synaptic reprogramming of the developing brain. Anissa Bara, Jacqueline Marie N. Ferland, Gregory Rompala, Henrietta Szutorisz, Yasmin L. Hurd. Nature Reviews Neuroscience

View All Publications

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Ferland has not yet completed reporting of Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Ferland has not yet completed reporting of Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.